Ion channels in the central regulation of energy and glucose homeostasis
- Division of Hypothalamic Research, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, USA
Ion channels are critical regulators of neuronal excitability and synaptic function in the brain. Recent evidence suggests that ion channels expressed by neurons within the brain are responsible for regulating energy and glucose homeostasis. In addition, the central effects of neurotransmitters and hormones are at least in part achieved by modifications of ion channel activity. This review focuses on ion channels and their neuronal functions followed by a discussion of the identified roles for specific ion channels in the central pathways regulating food intake, energy expenditure, and glucose balance.
Energy and glucose homeostasis is tightly regulated by mechanisms within the central nervous system (CNS) (Williams and Elmquist, 2012). Central neurons integrate peripheral and central signals for a coordinated modulation of food intake, energy expenditure, and glucose homeostasis (Williams and Elmquist, 2012). In recent years, researchers have utilized the Cre-loxP technology to selectively delete or reactivate receptors and signaling molecules of interest. Although this genetic strategy has some limitations including germ line expression of Cre transgenes and developmental compensation of missing molecules (Padilla et al., 2010, 2012; Morrison and Munzberg, 2012), the Cre-loxP technology has greatly contributed to determine the in vivo physiological roles for receptors, signaling molecules, neuropeptides and neurotransmitters in a neuron-specific manner. However, relatively little is known about the in vivo physiological function of ion channels expressed by central neurons. Importantly, neurotransmitters and hormones frequently alter the activity of ion channels to modify neuronal function involved in the central regulation of metabolism. Combined with mouse genetics and neuroanatomical approaches, electrophysiological techniques have been successfully applied to uncover novel roles for ion channels in the regulation of neurons by neurotransmitters and hormones (Cowley et al., 2001; Qiu et al., 2010; Klockener et al., 2011; Sohn et al., 2011, 2013; Vong et al., 2011; Cui et al., 2012; Liu et al., 2012). This review will focus on several ion channels that have been found to regulate neuronal function in vitro and/or to have metabolic effects in vivo. Thus, recent advances and current challenges in understanding the role of ion channels in central neurons regulating metabolism will be discussed.
Role of Ion Channels in Neuronal Activity
Ion channels are critical in regulating the membrane potential of neurons (Hille, 2001). Typically, the activation of a specific ion channel will either activate or inhibit a neuron depending on the resting membrane potential (RMP) and the ion's equilibrium potential (Figure 1). If RMP is more negative than the equilibrium potential of an ion, the cation will rush in through open channels (inward current) in the cell membrane which results in a depolarization of the membrane potential (e.g., Na+ channels, Ca2+ channels, and non-selective cation or NSC channels, Figure 1, pink-colored channels). By contrast, cations rush out or anions rush in through open channels (outward current) to hyperpolarize membrane potential when RMP is more positive than the equilibrium potential of an ion (e.g., K+ channels and Cl− channels, Figure 1, blue-colored channels). Typically, neurons within the arcuate nucleus of hypothalamus have a RMP of ~55 mV (Cowley et al., 2001; Hill et al., 2008; Al-Qassab et al., 2009; Williams et al., 2010; Sohn et al., 2011) (Figure 1). Thus, the activation of NSC channels will depolarize a cell because the estimated ENSC is approximately −20 mV (Cowley et al., 2001; Hill et al., 2008; Williams et al., 2010; Sohn et al., 2011) (Figure 1). By contrast, activation of K+ channels will hyperpolarize the membrane potential because EK is approximately −105 mV (Williams et al., 2010; Sohn et al., 2013) (Figure 1).
Figure 1. Ion channels and regulation of membrane excitability. Neurons within the arcuate nucleus typically have a RMP of ~55 mV (See text). Cations rush in through open channels when RMP is more negative to the equilibrium potentials (pink-colored channels). By contrast, cations rush out or anions rush in through open channels when RMP is more positive to the equilibrium potentials (blue-colored channels). Equilibrium potentials were calculated using Nernst equation assuming experimental conditions in Sohn et al. (2011).
The direct activation of most ion channels is triggered by either changes in voltage (voltage-gated channels) or neurotransmitters and hormones (ligand-gated channels). For instance, direct depolarization of neurons by electrical stimuli will open voltage-gated Na+, Ca2+, and K+ channels, which contribute to action potentials. Examples of ligand-gated channels include ionotropic receptors of glutamate and gamma-aminobutyric acid (GABA). While the slow actions of these neurotransmitters are mediated by the G-protein coupled metabotropic receptors (mGluRs and GABAB receptors), their fast actions are mediated by the ionotropic receptors (iGluRs and GABAA receptors) (Hammond, 2001). Glutamate released from presynaptic terminals activates the iGluRs (AMPA, kainate, or NMDA receptors; these are NSC channels) to generate excitatory postsynaptic potentials (EPSPs) (Hammond, 2001). Likewise, GABA activates the ionotropic GABAA receptors (these are chloride channels) to generate inhibitory postsynaptic potentials (IPSPs) (Hammond, 2001). In addition to these direct modes of ion channel activation, neurotransmitters and hormones bind to their cognate receptors and activate cellular signaling cascades, which ultimately results in the regulation of ion channel activity.
Ion Channels in the Central Regulation of Metabolism
Given the large contribution of the K+ conductance to RMP, neurotransmitters and hormones frequently target K+ channels to modify cellular activity. Once activated, K+ channels hyperpolarize the membrane potential and inhibit neuronal activity. If K+ channels are active at rest and contribute to stabilizing the membrane potential, the inhibition of K+ channels depolarizes membrane potential and enhances neuronal activity. As discussed below, two inward rectifier K+ channels (ATP-sensitive K+ channels and G protein-gated inwardly rectifying K+ channels) have been found to mediate central regulation of food intake, energy expenditure and glucose homeostasis.
ATP-sensitive K+ (KATP) channels
KATP (Kir6) channels belong to a subfamily of inward rectifier K+ channels gated by changes in intracellular ATP levels (Hibino et al., 2010). Functional KATP channels consist of four pore forming subunits Kir6.x (Kir6.1 or Kir6.2) and four regulatory subunits SURx (SUR1, SUR2A, or SUR2B) (Flagg et al., 2010; Hibino et al., 2010). Typically, KATP channel compositions are Kir6.2 + SUR1 in pancreatic beta cells, Kir6.2 + SUR2A in cardiac muscle cells, Kir6.1 + SUR2B in smooth muscle cells (Hibino et al., 2010). Low ATP levels open KATP channels while high ATP levels close these channels. For instance, in hyperglycemic conditions with elevated intracellular ATP levels, the inhibition of KATP channels leads to depolarization of pancreatic beta cells and insulin secretion (Hibino et al., 2010). By contrast, low intracellular ATP levels such as in coronary ischemia results in the opening of cardiac KATP channels and a hyperpolarization, which stabilizes cardiac myocytes (Flagg et al., 2010; Hibino et al., 2010). This is thought to protect the heart from further injury. Thus, KATP channels transform cellular energy status to electrical activity in pathophysiological settings.
KATP and other channels sense glucose levels in brain. KATP channels are widely expressed throughout the brain (Ashcroft, 1988). It is believed that neurons expressing KATP channels sense brain glucose levels and regulate glucose homeostasis by changing their excitability (Ashcroft, 1988). Elevated brain glucose levels activate glucose-excited (or glucose-reponsive) neurons via the inhibition of KATP channels in multiple brain areas including the ventromedial hypothalamic nucleus (VMH), the arcuate nucleus, and the lateral hypothalamic area (LHA) (Ashford et al., 1990; Song et al., 2001; Routh, 2002; Ibrahim et al., 2003; Wang et al., 2004; Burdakov et al., 2005; Claret et al., 2007) (Table 1). In brain, Kir6.2 has been suggested to be the pore-forming subunits (Karschin et al., 1998; Zawar et al., 1999; Miki et al., 2001), and defective Kir6.2 subunits resulted in non-functional KATP channels. For instance, it was demonstrated that genetic deletion of Kir6.2 subunits deprived VMH neurons of KATP currents as well as glucose responsiveness, and that glucagon secretion was defective in these mice (Miki et al., 2001). Notably, pancreatic alpha cell activity was normal in Kir6.2 knockout mice (Miki et al., 2001). It was also demonstrated that defective Kir6.2 subunits in specific neurons affect glucose homeostasis. For instance, mutant Kir6.2 subunits in arcuate pro-opiomelanocortin (POMC) neurons led to impaired POMC neuron glucose responsiveness and impaired whole body glucose tolerance (Parton et al., 2007). Moreover, melanin-concentrating hormone (MCH) neurons within LHA were not activated by elevated glucose levels when Kir6.2 subunits in these neurons lacked glucose-sensing amino acid residues: these mice also showed impaired glucose tolerance (Kong et al., 2010). Therefore, Kir6.2 subunits expressed by VMH neurons, arcuate POMC neurons, and LHA MCH neurons mediate glucose-excitation of these neurons. In addition, these results suggest that glucose sensing by these neurons are required for regulating whole body glucose homeostasis.
By contrast to the glucose-excitation of LHA MCH neurons (Burdakov et al., 2005; Kong et al., 2010), orexin/hypocretin neurons in LHA are inhibited by elevated glucose concentrations (glucose-inhibited or glucose-sensitive neurons) (Burdakov et al., 2005, 2006). The identity of ion channels underlying glucose-inhibition is still in debate. Earlier studies suggested the involvement of Na+-K+ ATPase and cystic fibrosis transmembrane regulator (CFTR)-like chloride conductance in the glucose inhibition (Oomura et al., 1974; Song et al., 2001; Routh, 2002; Fioramonti et al., 2007) (Table 1). Later, two-pore or tandem-pore domain K+ (K2P) channels were demonstrated to inhibit neuronal activity by elevated glucose concentrations in the orexin/hypocretin neurons of LHA (Burdakov et al., 2006) (Table 1). They claimed that TASK3 subunits, a subfamily of K2P channels, are responsible for the observed glucose-inhibition (Burdakov et al., 2006). However, genetic deletions of TASK1/TASK3 or TREK1/TREK2/TRAAK did not prevent glucose inhibition of orexin/hypocretin neurons (Guyon et al., 2009). These conflicting results highlight the requirement of better pharmacological and/or genetic tools to identify the molecular entity of ion channels underlying glucose inhibition of hypothalamic neurons.
KATP channels mediate the acute inhibitory effects of leptin and insulin. KATP channels also mediate metabolic effects of leptin and insulin, the anorexigenic hormones released from adipocytes and pancreatic beta cells, respectively (Williams et al., 2011a). In the arcuate nucleus, enhanced PIP3 signaling and increased KATP channel activity in POMC neurons led to hyperphagia and diet-induced obesity at least in part by blunting the acute effects of leptin and insulin (Plum et al., 2006). In the VMH, insulin receptors expressed by the SF-1 neurons were shown to activate KATP channels and suppress SF-1 neuron activity, which resulted in diet-induced obesity (Klockener et al., 2011). More recently, increased mTOR signaling was associated with elevated KATP channel activity in arcuate POMC neurons resulting in the cellular inhibition of arcuate POMC neurons concomitant with age-dependent obesity (Yang et al., 2012).
Leptin is well known for its anti-obesity and anti-diabetic effects (Zhang et al., 1994; Campfield et al., 1995; Farooqi et al., 1999). Evidence suggests that leptin effects are largely mediated via mechanisms in the CNS (Campfield et al., 1995; Halaas et al., 1995, 1997; Cohen et al., 2001; Spiegelman and Flier, 2001). Similarly, insulin levels in the brain are increased in proportion to blood levels, and some of insulin effects are mediated via mechanisms in the CNS (Woods et al., 1979; Obici et al., 2002). While leptin and insulin effects on energy and glucose homeostasis are largely mediated by Jak2/STAT3 and Akt/FOXO1 signaling cascades, respectively (Belgardt and Bruning, 2010), they also require phosphatidylinositol-3-kinase (PI3K) activity (Niswender et al., 2001; Zhao et al., 2002; Rahmouni et al., 2003; Mirshamsi et al., 2004; Morrison et al., 2005; Morton et al., 2005; Fukuda et al., 2008). Interestingly, the acute cellular effects of leptin and insulin are also mediated via PI3K activation (Choudhury et al., 2005; Plum et al., 2006; Hill et al., 2008; Al-Qassab et al., 2009; Klockener et al., 2011; Williams et al., 2011b) (Figure 2). The acute inhibition of cellular activity by leptin is mediated by the activation of KATP channels, as demonstrated by findings in several types of neurons located in hypothalamus and brainstem (Spanswick et al., 1997; Williams and Smith, 2006; Cui et al., 2012) (Figure 2 and Table 1). Typically, arcuate POMC neurons and leptin receptor (LepR)-expressing neurons of ventral premammilary nucleus (PMV) are activated by leptin (Cowley et al., 2001; Al-Qassab et al., 2009; Williams et al., 2010, 2011b) (Table 1). However, a minor population of arcuate POMC neurons and PMV LepR neurons is inhibited by leptin via KATP channel activation (Williams et al., 2010, 2011b) (Table 1). By contrast to leptin effects, acute effects of insulin are mostly inhibitory and mediated via the activation of KATP channels in neurons of VMH and arcuate nucleus (Spanswick et al., 2000; Hill et al., 2008; Williams et al., 2010; Klockener et al., 2011) (Figure 2 and Table 1). It was also reported, however, that insulin activated some arcuate neuropeptide Y (NPY)/agouti-related peptide (AgRP) neurons (Al-Qassab et al., 2009) (Table 1). In addition, although PI3K closely interact with Jak2/STAT3 and Akt/FOXO1 signaling cascades (Belgardt and Bruning, 2010; Williams et al., 2011a), there is currently no available data liking these signaling cascades to PI3K/KATP channel activation. Thus, while PI3K mediates the acute effects of leptin and insulin, more efforts are required to better understand the ion channel mechanisms and relevant signal pathways.
Figure 2. Receptor-mediated regulation of KATP channels. MC4Rs, which are Gs protein-coupled receptors, activate KATP channels via the cAMP/PKA signaling pathways. On the other hand, leptin receptors (type 1 cytokine receptors) and insulin receptors (class 2 tyrosine kinase receptors) activate KATP channels via the PI3K signaling pathway.
Arcuate POMC and NPY/AgRP neurons and VMH SF1 neurons are common targets of leptin and insulin (Al-Qassab et al., 2009; Williams et al., 2010; Klockener et al., 2011). As discussed, the acute effects of both leptin and insulin are mediated by the PI3K-dependent signaling pathways (Al-Qassab et al., 2009; Klockener et al., 2011; Williams et al., 2011b). However, their cellular effects are heterogeneous depending on their target neurons. POMC neurons and SF1 neurons are either activated or inhibited by leptin, and inhibited by insulin (Al-Qassab et al., 2009; Williams et al., 2010; Klockener et al., 2011). NPY/AgRP neurons are inhibited by leptin, but either inhibited or activated by insulin (Al-Qassab et al., 2009; Williams et al., 2010). Interestingly, leptin-activated, leptin-inhibited, and insulin-inhibited neurons have been found to be distinct within the POMC neuron population (Williams et al., 2010) and SF1 neuron population (Klockener et al., 2011). Thus, while leptin and insulin share the PI3K signaling pathways for their acute effects, it looks like they act on distinct populations of neurons. Given the divergent axonal projections of these neurons (Canteras et al., 1994; Baker and Herkenham, 1995; Elias et al., 1998, 2001; Bagnol et al., 1999), it will be an interesting focus of future investigation to delineate the relationship between leptin/insulin responsiveness of these neurons and their axonal projections.
KATP channels mediate the acute inhibitory effects of melanocotins. Melanocortin 4 receptors (MC4Rs) are important regulators of energy and glucose homeostasis (Huszar et al., 1997; Vaisse et al., 1998; Yeo et al., 1998; Farooqi et al., 2003). MC4Rs are expressed by distinct nuclei in the CNS (Kishi et al., 2003; Liu et al., 2003). Interestingly, MC4Rs in the paraventricular hypothalamic nucleus (PVH) decrease food intake whereas MC4Rs expressed by cholinergic neurons (including parasympathetic and sympathetic preganglionic neurons) increase energy expenditure and regulate glucose homeostasis, suggesting a divergence of the central melanocortin pathways (Balthasar et al., 2005; Rossi et al., 2011). MC4Rs are demonstrated to depolarize neurons within the PVH and dorsomedial hypothalamic nucleus (DMH) (Liu et al., 2003), but little is known about the specific ion channel mediating the acute effects of MC4Rs in these neurons (Table 1). It was suggested that the inhibition of multiple potassium channels underlies MC4R-induced depolarization of arcuate POMC neurons (Smith et al., 2007) (Table 1). In POMC neurons, however, a distinct physiological role of MC4Rs has not yet been characterized. A recent study demonstrated that MC4Rs hyperpolarize the parasympathetic preganglionic neurons in brainstem via PKA-dependent activation of KATP channels (Sohn et al., 2013) (Figure 2 and Table 1). Interestingly, it was shown in the same study that MC4Rs depolarize the sympathetic preganglionic neurons in spinal cord (Sohn et al., 2013) (Table 1). These results represent a reciprocal regulation of autonomic preganglionic neurons. The identity of ion channels underlying the depolarization of PVH/DMH neurons and the sympathetic preganglionic neurons has not yet been determined. Further experiments will be necessary to delineate the intracellular signal pathways and the target ion channels underlying the cellular effects of MC4Rs in CNS.
G protein-gated inwardly rectifying K+ (GIRK) channels
GIRK (Kir3) channels are a subfamily of inwardly rectifying K+ channels gated by G protein-coupled receptors (Hibino et al., 2010). GIRK channels are important regulators of RMP and cellular excitability in the heart and brain (Luscher et al., 1997; Wickman et al., 1998; Cruz et al., 2004; Luscher and Slesinger, 2010). There are four mammalian GIRK channel subunits, GIRK1~GIRK4. GIRK1/GIRK2 heterotetramers serve as the neuronal GIRK channel prototype, while cardiac GIRK channels are GIRK1/GIRK4 heterotetramers (Koyrakh et al., 2005; Luscher and Slesinger, 2010). Since GIRK1 homomers fail to form a functional GIRK channel, the knockout of GIRK2 subunits eliminates most GIRK currents in brain (Krapivinsky et al., 1995; Hedin et al., 1996; Kennedy et al., 1996, 1999; Ma et al., 2002). However, deficiency in GIRK2 subunits did not affect RMP of arcuate POMC neurons (Sohn et al., 2011). Notably, GIRK1 subunits were found to be largely responsible for stabilizing the membrane potential of arcuate POMC neurons (Sohn et al., 2011). In addition, global deficiency of GIRK4 subunits resulted in mice that developed late onset obesity through hypothalamic mechanisms (Perry et al., 2008). Thus, subunit composition of hypothalamic GIRK channels may be distinct from those identified in other brain areas including hippocampus and midbrain.
GIRK channels may be constitutively active (Chen and Johnston, 2005; Sohn et al., 2011), but they are more commonly activated by the direct binding of Gβγ subunits originating from Gi/o protein-coupled receptors including Y receptors, GABAB receptors, and opioid receptors (Figure 3). For instance, the hyperpolarizing effects of Y1R/Y2R are mediated by the activation of GIRK channels in the orexin/hypocretin neurons within LHA (Fu et al., 2004), the glutamatergic neurons within VMH (Chee et al., 2010) and the GABAergic neurons and POMC neurons within arcuate nucleus (Roseberry et al., 2004; Acuna-Goycolea et al., 2005) (Table 1). Recent evidence demonstrated that dynorphin, an endogenous opioid neuropeptide, inhibits arcuate POMC neurons via activation of κ2 opioid receptors and GIRK channels (Zhang and Van Den Pol, 2013). Likewise, GIRK channels are likely to underlie the slow inhibitory effects of serotonin 1B receptors (5-HT1BRs) on arcuate NPY/AgRP neurons (Heisler et al., 2006). GIRK channels also mediate slow inhibitory effects of the metabotropic GABAB receptors in arcuate POMC neurons (Sohn et al., 2011). Recently it was shown that arcuate POMC neuronal activity was regulated by changes in the GABAergic inhibitory postsynaptic currents (IPSCs), which are chloride currents through the ionotropic GABAA receptors. (Tong et al., 2008; Vong et al., 2011). It is also possible that changes in GABAergic neurotransmission may also regulate arcuate POMC neurons via the GABAB receptors and GIRK channels. However, this possibility has not yet been tested. Identifying the role of specific GIRK channel subunits in hypothalamus will be an interesting focus of future investigation.
Figure 3. Receptor-mediated regulation of GIRK channels. GIRK channels are activated by the direct binding of Gβγ subunits in a membrane-delimited manner. Typically, Gβγ subunits which open GIRK channels originate from the Gi/o protein-coupled receptors such as Y receptors, GABAB receptors, and κ2 opioid receptors.
Non-Selective Cation (NSC) Channels
NSC channels refer to a collection of ion channels that permeate cations (e.g., Na+, K+, and Ca2+) without ion selectivity. The relative conductance to each cation is different for each channel, but they typically have a reversal potential around −20 mV (Cowley et al., 2001; Hill et al., 2008; Sohn et al., 2011). The transient receptor potential (TRP) channel is the largest and probably the best-studied NSC channel family (Wu et al., 2010). Mammalian homologues of Drosophila TRP channels have been classified into subfamilies including canonical (TRPC), vanilloid (TRPV), melastatin (TRPM), and others (Wu et al., 2010). TRP channels are expressed widely in the CNS (Wu et al., 2010), and specific functions for each channel are being discovered. Mice with defective TRPC3 channels showed cerebellar locomotive dysfunction (Hartmann et al., 2008). In addition, TRPC5 channel knockout mice showed decreased fear (Riccio et al., 2009), and TRPV1 channel was found to be responsible for addiction and pain (Grueter et al., 2010; Kim et al., 2012).
As discussed, leptin-induced hyperpolarization is attributed to the activation of KATP channels. By contrast, leptin depolarizes arcuate POMC neurons via the activation of NSC conductance (Cowley et al., 2001; Hill et al., 2008). It was later demonstrated that leptin-induced inward currents in POMC neurons were mediated by PI3K/PLC-dependent activation of TRPC channels (Qiu et al., 2010) (Figure 4 and Table 1). Depolarization of PMV LepR neurons and arcuate kiss1 neurons was also attributed to the activation of TRPC channels (Qiu et al., 2011; Williams et al., 2011b) (Table 1). Analyses of biophysical characteristics and single cell RT-PCR results suggested that TRPC4 and TRPC5 subunits, and TPRC6 to a lesser extent, may underlie leptin-induced neuronal activation (Qiu et al., 2010, 2011). Thus, leptin activation of central neurons is expected to be largely mediated via TRPC channels. However, the specific TRPC subunit mediating the acute effects of leptin (in vitro and in vivo) still remains undefined.
Figure 4. Receptor-mediated regulation of TRPC channels. 5-HT2C receptors (Gq protein-coupled receptors) and leptin receptors (type 1 cytokine receptors) open TRPC channels via the PLC signaling pathway. Note that leptin receptors activate PI3K prior to PLC activation.
Serotonin 2C receptors (5-HT2CRs) expressed by arcuate POMC neurons are important in mediating the anti-obesity and anti-diabetic effects of serotonin (Heisler et al., 2002; Xu et al., 2008, 2010). It was also suggested that 5-HT1BRs expressed by arcuate NPY/AgRP neurons may underlie these effects of serotonin (Heisler et al., 2006). It was initially demonstrated that 5-HT2CRs directly activate the anorexigenic POMC neurons (Heisler et al., 2002). Notably, 5-HT1BRs directly inhibit the orexigenic NPY/AgRP neurons, which results in decreased IPSCs onto POMC neurons (Heisler et al., 2006). Thus, there is a local circuit involving arcuate POMC and NPY/AgRP neurons that mediates the anorexigenic effects of serotonin. More recently, it was shown that 5-HT2CRs activate arcuate POMC neurons via PLC-dependent activation of TRPC channels (Sohn et al., 2011) (Figure 4). Thus, TRPC channels may serve as a common cellular target to mediate the acute effects of both leptin and serotonin (Figure 4 and Table 1). As suggested for acute effects of leptin and insulin (Williams et al., 2010), leptin and serotonin activated distinct subpopulations of arcuate POMC neurons (Sohn et al., 2011). The heterogeneity of arcuate POMC neurons may be related to the divergence of central melanocortin pathways (Balthasar et al., 2005; Sohn and Williams, 2012). It should be noted that 5-HT2CRs also inhibit GIRK channels and M-type K+ channels in arcuate POMC neurons (Qiu et al., 2007; Roepke et al., 2012). Since these K+ channels stabilize neuronal RMP, the inhibition of these channels may also contribute to neuronal activation by 5-HT2CRs (Delmas and Brown, 2005; Luscher and Slesinger, 2010).
In addition to leptin and serotonin, depolarization of arcuate NPY/AgRP neurons by neuromedin B and gastrin-releasing peptide is mediated by the activation of NSC conductance (Van Den Pol et al., 2009). Also, there are examples of membrane depolarization with unidentified ion channel mechanisms. For instance, ghrelin, an orexigenic hormone released from gastric mucosa, depolarizes arcuate NPY/AgRP neurons (Cowley et al., 2003) (Table 1). Moreover, MC4Rs are known to depolarize arcuate POMC neurons (Smith et al., 2007), neurons within the PVH and DMH (Liu et al., 2003), and the sympathetic preganglionic neurons (Sohn et al., 2013). Currently, it's unclear if these acute effects involve NSC channels such as TRP channels and cyclic nucleotide gated (CNG) channels.
Ionotropic Glutamate Receptors (iGluRs) and GABAA Receptors
Neuronal excitability is frequently modulated by the excitatory neurotransmitter glutamate and the inhibitory neurotransmitter GABA released from presynaptic terminals (Pinto et al., 2004). Patch clamp electrophysiological recordings demonstrated abundant excitatory and inhibitory synaptic inputs onto both arcuate POMC neurons and NPY/AgRP neurons (Pinto et al., 2004; Sternson et al., 2005; Tong et al., 2008; Vong et al., 2011; Liu et al., 2012). The physiological importance of presynaptic glutamate release and postsynaptic iGluRs has been demonstrated in several studies. For instance, glutamate release machinery (vesicular glutamate transporter: vGluT2) in VMH SF-1 neurons was required to prevent hypoglycemia (Tong et al., 2007). In another study, food deprivation and ghrelin potentiated presynaptic glutamate release and increased spontaneous excitatory postsynaptic currents (sEPSCs) onto arcuate NPY/AgRP neurons (Yang et al., 2011). Recent studies highlighted the importance of NMDA receptors in fasting activation of arcuate NPY/AgRP neurons (Liu et al., 2012), and in relaying satiety signals from the nucleus tractus solitaries (NTS) to the parabrachial nucleus (PBN) (Wu et al., 2012).
Arcuate POMC neurons receive GABAergic input from multiple types of neurons including arcuate NPY/AgRP neurons (Cowley et al., 2001). The spontaneous IPSCs (sIPSCs) recorded in arcuate POMC neurons represented suppression of arcuate POMC neurons and alpha-MSH release (Tong et al., 2008; Vong et al., 2011). Defective synaptic GABA release from arcuate NPY/AgRP neurons produced a lean phenotype, which was associated with decreased IPSCs onto arcuate POMC neurons (Tong et al., 2008). In addition, deletion of LepRs in GABAergic neurons (probably non-NPY/AgRP) produced robust obesity (Vong et al., 2011), and this was associated with increased IPSCs onto arcuate POMC neurons. Notably, ghrelin increases IPSC frequency onto arcuate POMC neurons (Cowley et al., 2003; Tong et al., 2008), which may explain its orexigenic effects at least in part. Based on these results, it was suggested that GABAA receptors expressed by arcuate POMC neurons may be important regulators of energy and glucose homeostasis. However, it should be noted that deletion of LepRs in POMC neurons, which may decrease neuronal firing frequency, resulted in only a mild obesity with no increase in food intake (Balthasar et al., 2004). In addition, recent studies demonstrated that GABAergic neurotransmission in the PVH and the PBN is important for the orexigenic effects of NPY/AgRP neuron stimulation (Wu et al., 2009; Atasoy et al., 2012). Thus, the observed alteration of IPSC frequency onto the arcuate POMC neurons may not be so critical as previously suggested for the metabolic effects observed in those mouse models (Cowley et al., 2003; Tong et al., 2008; Vong et al., 2011). Future studies may need to delineate the relative contribution of GABAergic neurotransmission and the role of GABAA receptors expressed by arcuate POMC neurons and the neurons within PVH and PBN.
In summary, multiple ion channels expressed by a specific neuron contribute to determine cellular response to humoral or synaptic inputs. For instance, KATP channels expressed by arcuate POMC neurons underlie the acute cellular inhibition by insulin receptors (Hill et al., 2008; Williams et al., 2010). On the other hand, the acute cellular activation by LepRs and 5-HT2CRs are mediated by TRPC channels (Hill et al., 2008; Qiu et al., 2010; Williams et al., 2010; Sohn et al., 2011). In addition, GABAA receptors are responsible for the fast inhibitory inputs (IPSCs) from NPY/AgRP and other GABAergic neurons (Cowley et al., 2001; Vong et al., 2011). Notably, these GABAergic neurons are modulated by leptin and ghrelin and therefore the changes in IPSCs recorded on arcuate POMC neurons may represent indirect effects of these hormones (Cowley et al., 2003; Pinto et al., 2004; Tong et al., 2008; Vong et al., 2011). Although direct evidence is lacking, it is possible that EPSCs recorded on arcuate POMC neurons may represent the glutamatergic input from VMH SF1 neurons (Sternson et al., 2005). Considering that glutamate release from SF1 neurons regulate glucose homeostasis (Tong et al., 2007), it will be worthwhile to study the role of iGluRs expressed by arcuate POMC neurons in glucose homeostasis. More specific functions of ion channels are expected to be discovered regarding the central regulation of food intake, energy expenditure, and glucose homeostasis.
Most of currently available data regarding the in vivo effects of hormones and neurotransmitters on metabolism was obtained by neuron-specific deletions of receptors or downstream signaling molecules using the Cre-loxP technology (Balthasar et al., 2005; Dhillon et al., 2006; Hill et al., 2008, 2010; Al-Qassab et al., 2009; Xu et al., 2010; Klockener et al., 2011; Rossi et al., 2011; Scott et al., 2011). While hormones and neurotransmitters frequently modulate ion channels in vitro, little is known about a specific function of ion channels in central regulation of metabolism in vivo. Recent evidence suggests that defective ion channel subunits in specific neuronal populations could lead to a long-term dysregulation of energy and glucose homeostasis (Parton et al., 2007; Liu et al., 2012). For a direct evaluation of how ion channels contribute to central regulation of metabolism, it will be reasonable to generate mice that have loxP-flanked ion channel genes and breed them with available Cre mouse models. Considering the importance of ion channels in neuronal and synaptic function, these studies will certainly advance our knowledge on the central mechanisms regulating energy and glucose homeostasis.
Conflict of Interest Statement
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
This work was supported by the American Heart Association Postdoctoral Fellowship (AHA 12POST8860007) to Jong-Woo Sohn.
Acuna-Goycolea, C., Tamamaki, N., Yanagawa, Y., Obata, K., and Van Den Pol, A. N. (2005). Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J. Neurosci. 25, 7406–7419.
Al-Qassab, H., Smith, M. A., Irvine, E. E., Guillermet-Guibert, J., Claret, M., Choudhury, A. I., et al. (2009). Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons. Cell Metab. 10, 343–354.
Bagnol, D., Lu, X. Y., Kaelin, C. B., Day, H. E., Ollmann, M., Gantz, I., et al. (1999). Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J. Neurosci. 19, RC26.
Baker, R. A., and Herkenham, M. (1995). Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat. J. Comp. Neurol. 358, 518–530.
Balthasar, N., Dalgaard, L. T., Lee, C. E., Yu, J., Funahashi, H., Williams, T., et al. (2005). Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123, 493–505.
Burdakov, D., Gerasimenko, O., and Verkhratsky, A. (2005). Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. J. Neurosci. 25, 2429–2433.
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., and Burn, P. (1995). Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546–549.
Canteras, N. S., Simerly, R. B., and Swanson, L. W. (1994). Organization of projections from the ventromedial nucleus of the hypothalamus: a Phaseolus vulgaris-leucoagglutinin study in the rat. J. Comp. Neurol. 348, 41–79.
Choudhury, A. I., Heffron, H., Smith, M. A., Al-Qassab, H., Xu, A. W., Selman, C., et al. (2005). The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J. Clin. Invest. 115, 940–950.
Claret, M., Smith, M. A., Batterham, R. L., Selman, C., Choudhury, A. I., Fryer, L. G., et al. (2007). AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J. Clin. Invest. 117, 2325–2336.
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdan, M. G., Diano, S., Horvath, T. L., et al. (2001). Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480–484.
Cowley, M. A., Smith, R. G., Diano, S., Tschop, M., Pronchuk, N., Grove, K. L., et al. (2003). The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649–661.
Cruz, H. G., Ivanova, T., Lunn, M. L., Stoffel, M., Slesinger, P. A., and Luscher, C. (2004). Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system. Nat. Neurosci. 7, 153–159.
Cui, H., Sohn, J. W., Gautron, L., Funahashi, H., Williams, K. W., Elmquist, J. K., et al. (2012). Neuroanatomy of melanocortin-4 receptor pathway in the lateral hypothalamic area. J. Comp. Neurol. 520, 4168–4183.
Dhillon, H., Zigman, J. M., Ye, C., Lee, C. E., McGovern, R. A., Tang, V., et al. (2006). Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 49, 191–203.
Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., et al. (1999). Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341, 879–884.
Farooqi, I. S., Keogh, J. M., Yeo, G. S., Lank, E. J., Cheetham, T., and O'Rahilly, S. (2003). Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348, 1085–1095.
Fioramonti, X., Contie, S., Song, Z., Routh, V. H., Lorsignol, A., and Penicaud, L. (2007). Characterization of glucosensing neuron subpopulations in the arcuate nucleus: integration in neuropeptide Y and pro-opio melanocortin networks? Diabetes 56, 1219–1227.
Fu, L. Y., Acuna-Goycolea, C., and Van Den Pol, A. N. (2004). Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J. Neurosci. 24, 8741–8751.
Guyon, A., Tardy, M. P., Rovere, C., Nahon, J. L., Barhanin, J., and Lesage, F. (2009). Glucose inhibition persists in hypothalamic neurons lacking tandem-pore K+ channels. J. Neurosci. 29, 2528–2533.
Halaas, J. L., Boozer, C., Blair-West, J., Fidahusein, N., Denton, D. A., and Friedman, J. M. (1997). Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. U.S.A. 94, 8878–8883.
Hartmann, J., Dragicevic, E., Adelsberger, H., Henning, H. A., Sumser, M., Abramowitz, J., et al. (2008). TRPC3 channels are required for synaptic transmission and motor coordination. Neuron 59, 392–398.
Hibino, H., Inanobe, A., Furutani, K., Murakami, S., Findlay, I., and Kurachi, Y. (2010). Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol. Rev. 90, 291–366.
Hill, J. W., Elias, C. F., Fukuda, M., Williams, K. W., Berglund, E. D., Holland, W. L., et al. (2010). Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metab. 11, 286–297.
Hill, J. W., Williams, K. W., Ye, C., Luo, J., Balthasar, N., Coppari, R., et al. (2008). Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. J. Clin. Invest. 118, 1796–1805.
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., et al. (1997). Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131–141.
Ibrahim, N., Bosch, M. A., Smart, J. L., Qiu, J., Rubinstein, M., Ronnekleiv, O. K., et al. (2003). Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels. Endocrinology 144, 1331–1340.
Kennedy, M. E., Nemec, J., Corey, S., Wickman, K., and Clapham, D. E. (1999). GIRK4 confers appropriate processing and cell surface localization to G-protein-gated potassium channels. J. Biol. Chem. 274, 2571–2582.
Kim, Y. H., Back, S. K., Davies, A. J., Jeong, H., Jo, H. J., Chung, G., et al. (2012). TRPV1 in GABAergic interneurons mediates neuropathic mechanical allodynia and disinhibition of the nociceptive circuitry in the spinal cord. Neuron 74, 640–647.
Kishi, T., Aschkenasi, C. J., Lee, C. E., Mountjoy, K. G., Saper, C. B., and Elmquist, J. K. (2003). Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J. Comp. Neurol. 457, 213–235.
Klockener, T., Hess, S., Belgardt, B. F., Paeger, L., Verhagen, L. A., Husch, A., et al. (2011). High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons. Nat. Neurosci. 14, 911–918.
Kong, D., Vong, L., Parton, L. E., Ye, C., Tong, Q., Hu, X., et al. (2010). Glucose stimulation of hypothalamic MCH neurons involves K(ATP) channels, is modulated by UCP2, and regulates peripheral glucose homeostasis. Cell Metab. 12, 545–552.
Koyrakh, L., Lujan, R., Colon, J., Karschin, C., Kurachi, Y., Karschin, A., et al. (2005). Molecular and cellular diversity of neuronal G-protein-gated potassium channels. J. Neurosci. 25, 11468–11478.
Krapivinsky, G., Gordon, E. A., Wickman, K., Velimirovic, B., Krapivinsky, L., and Clapham, D. E. (1995). The G-protein-gated atrial K+ channel IKACh is a heteromultimer of two inwardly rectifying K(+)-channel proteins. Nature 374, 135–141.
Liu, H., Kishi, T., Roseberry, A. G., Cai, X., Lee, C. E., Montez, J. M., et al. (2003). Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J. Neurosci. 23, 7143–7154.
Liu, T., Kong, D., Shah, B. P., Ye, C., Koda, S., Saunders, A., et al. (2012). Fasting activation of AgRP neurons requires NMDA receptors and involves spinogenesis and increased excitatory tone. Neuron 73, 511–522.
Luscher, C., Jan, L. Y., Stoffel, M., Malenka, R. C., and Nicoll, R. A. (1997). G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron 19, 687–695.
Ma, D., Zerangue, N., Raab-Graham, K., Fried, S. R., Jan, Y. N., and Jan, L. Y. (2002). Diverse trafficking patterns due to multiple traffic motifs in G protein-activated inwardly rectifying potassium channels from brain and heart. Neuron 33, 715–729.
Miki, T., Liss, B., Minami, K., Shiuchi, T., Saraya, A., Kashima, Y., et al. (2001). ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat. Neurosci. 4, 507–512.
Mirshamsi, S., Laidlaw, H. A., Ning, K., Anderson, E., Burgess, L. A., Gray, A., et al. (2004). Leptin and insulin stimulation of signalling pathways in arcuate nucleus neurones: PI3K dependent actin reorganization and KATP channel activation. BMC Neurosci. 5:54. doi: 10.1186/1471-2202-5-54
Morrison, C. D., Morton, G. J., Niswender, K. D., Gelling, R. W., and Schwartz, M. W. (2005). Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling. Am. J. Physiol. Endocrinol. Metab. 289, E1051–E1057.
Morton, G. J., Gelling, R. W., Niswender, K. D., Morrison, C. D., Rhodes, C. J., and Schwartz, M. W. (2005). Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. Cell Metab. 2, 411–420.
Padilla, S. L., Reef, D., and Zeltser, L. M. (2012). Defining POMC neurons using transgenic reagents: impact of transient Pomc expression in diverse immature neuronal populations. Endocrinology 153, 1219–1231.
Parton, L. E., Ye, C. P., Coppari, R., Enriori, P. J., Choi, B., Zhang, C. Y., et al. (2007). Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 449, 228–232.
Perry, C. A., Pravetoni, M., Teske, J. A., Aguado, C., Erickson, D. J., Medrano, J. F., et al. (2008). Predisposition to late-onset obesity in GIRK4 knockout mice. Proc. Natl. Acad. Sci. U.S.A. 105, 8148–8153.
Plum, L., Ma, X., Hampel, B., Balthasar, N., Coppari, R., Munzberg, H., et al. (2006). Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity. J. Clin. Invest. 116, 1886–1901.
Qiu, J., Xue, C., Bosch, M. A., Murphy, J. G., Fan, W., Ronnekleiv, O. K., et al. (2007). Serotonin 5-hydroxytryptamine2C receptor signaling in hypothalamic proopiomelanocortin neurons: role in energy homeostasis in females. Mol. Pharmacol. 72, 885–896.
Roepke, T. A., Smith, A. W., Ronnekleiv, O. K., and Kelly, M. J. (2012). Serotonin 5-HT2C receptor-mediated inhibition of the M-current in hypothalamic POMC neurons. Am. J. Physiol. Endocrinol. Metab. 302, E1399–E1406.
Roseberry, A. G., Liu, H., Jackson, A. C., Cai, X., and Friedman, J. M. (2004). Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 41, 711–722.
Rossi, J., Balthasar, N., Olson, D., Scott, M., Berglund, E., Lee, C. E., et al. (2011). Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis. Cell Metab. 13, 195–204.
Scott, M. M., Williams, K. W., Rossi, J., Lee, C. E., and Elmquist, J. K. (2011). Leptin receptor expression in hindbrain Glp-1 neurons regulates food intake and energy balance in mice. J. Clin. Invest. 121, 2413–2421.
Smith, M. A., Hisadome, K., Al-Qassab, H., Heffron, H., Withers, D. J., and Ashford, M. L. (2007). Melanocortins and agouti-related protein modulate the excitability of two arcuate nucleus neuron populations by alteration of resting potassium conductances. J. Physiol. 578, 425–438.
Sohn, J. W., Harris, L. E., Berglund, E. D., Liu, T., Vong, L., Lowell, B. B., et al. (2013). Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons. Cell 152, 612–619.
Sohn, J. W., Xu, Y., Jones, J. E., Wickman, K., Williams, K. W., and Elmquist, J. K. (2011). Serotonin 2C receptor activates a distinct population of arcuate pro-opiomelanocortin neurons via TRPC channels. Neuron 71, 488–497.
Song, Z., Levin, B. E., McArdle, J. J., Bakhos, N., and Routh, V. H. (2001). Convergence of pre- and postsynaptic influences on glucosensing neurons in the ventromedial hypothalamic nucleus. Diabetes 50, 2673–2681.
Spanswick, D., Smith, M. A., Mirshamsi, S., Routh, V. H., and Ashford, M. L. (2000). Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nat. Neurosci. 3, 757–758.
Tong, Q., Ye, C., McCrimmon, R. J., Dhillon, H., Choi, B., Kramer, M. D., et al. (2007). Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metab. 5, 383–393.
Tong, Q., Ye, C. P., Jones, J. E., Elmquist, J. K., and Lowell, B. B. (2008). Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nat. Neurosci. 11, 998–1000.
Van Den Pol, A. N., Yao, Y., Fu, L. Y., Foo, K., Huang, H., Coppari, R., et al. (2009). Neuromedin B and gastrin-releasing peptide excite arcuate nucleus neuropeptide Y neurons in a novel transgenic mouse expressing strong Renilla green fluorescent protein in NPY neurons. J. Neurosci. 29, 4622–4639.
Wang, R., Liu, X., Hentges, S. T., Dunn-Meynell, A. A., Levin, B. E., Wang, W., et al. (2004). The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 53, 1959–1965.
Williams, K. W., Margatho, L. O., Lee, C. E., Choi, M., Lee, S., Scott, M. M., et al. (2010). Segregation of acute leptin and insulin effects in distinct populations of arcuate proopiomelanocortin neurons. J. Neurosci. 30, 2472–2479.
Williams, K. W., Scott, M. M., and Elmquist, J. K. (2011a). Modulation of the central melanocortin system by leptin, insulin, and serotonin: co-ordinated actions in a dispersed neuronal network. Eur. J. Pharmacol. 660, 2–12.
Williams, K. W., Sohn, J. W., Donato, J. Jr., Lee, C. E., Zhao, J. J., Elmquist, J. K., et al. (2011b). The acute effects of leptin require PI3K signaling in the hypothalamic ventral premammillary nucleus. J. Neurosci. 31, 13147–13156.
Wu, L. J., Sweet, T. B., and Clapham, D. E. (2010). International union of basic and clinical pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol. Rev. 62, 381–404.
Xu, Y., Berglund, E. D., Sohn, J. W., Holland, W. L., Chuang, J. C., Fukuda, M., et al. (2010). 5-HT(2C)Rs expressed by pro-opiomelanocortin neurons regulate insulin sensitivity in liver. Nat. Neurosci. 13, 1457–1459.
Yang, S. B., Tien, A. C., Boddupalli, G., Xu, A. W., Jan, Y. N., and Jan, L. Y. (2012). Rapamycin ameliorates age-dependent obesity associated with increased mtor signaling in hypothalamic POMC neurons. Neuron 75, 425–436.
Yeo, G. S., Farooqi, I. S., Aminian, S., Halsall, D. J., Stanhope, R. G., and O'Rahilly, S. (1998). A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20, 111–112.
Keywords: patch clamp electrophysiology, obesity, diabetes mellitus, K+ channels, TRPC channels, ionotropic glutamate receptors (iGluRs), GABAA receptors
Citation: Sohn J-W (2013) Ion channels in the central regulation of energy and glucose homeostasis. Front. Neurosci. 7:85. doi: 10.3389/fnins.2013.00085
Received: 29 December 2012; Accepted: 08 May 2013;
Published online: 23 May 2013.
Edited by:Michael Scott, University of Virginia, USA
Reviewed by:Masoud Ghamari-langroudi, Vanderbilt University, USA
Xingxing Kong, Harvard Medical School, USA
Hongxia Ren, Columbia University, USA
Copyright © 2013 Sohn. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
*Correspondence: Jong-Woo Sohn, Division of Hypothalamic Research, Department of Internal Medicine, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9077, USA. e-mail: firstname.lastname@example.org